Ost-müük Eagle Pharm - EGRX CFD
Lisa lemmikuks- Kokkuvõte
- Ajaloolised andmed
- Sündmused
- Tuluaruanne
- Bilanss
- Rahavood
- Omand
Hinnavahe | - | ||||||||
Pika positsiooni ööpäeva tasu
Long position overnight fee
Mine platvormile | -0.024874% | ||||||||
Lühikese positsiooni ööpäeva tasu
Short position overnight fee
Mine platvormile | 0.002651% | ||||||||
Ööpäeva tasu aeg | 21:00 (UTC) | ||||||||
Min kauplemise kogus | 1 | ||||||||
Valuuta | USD | ||||||||
Tagatis | 20% | ||||||||
Aktsiabörs | United States of America | ||||||||
Kauplemise vahendustasu | 0% |
*Information provided by Capital.com
Eelmine sulgemine* | N/A |
Avatud* | N/A |
Aastane muutus* | N/A |
Päeva ulatus* | N/A |
52 nädala ulatus | 23.87-51.60 |
Keskmine maht (10 päeva) | 289.29K |
Keskmine maht (3 kuud) | 3.43M |
Turukapitalisatsioon | 364.79M |
P/E suhtarv | 10.11 |
Ringluses olevad aktsiad | 13.08M |
Tulu | 316.61M |
EPS | 2.76 |
Dividendid (% kasumist) | N/A |
Beeta | 0.91 |
Järgmine tuluaruande kuupäev | May 8, 2023 |
Kõigi andmete allikas on Refinitiv, välja arvatud tärniga märgitud, kus *-ga andmed on esitanud Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Sulgemishind | Change (%) | Avamishind | High | Low |
---|
Eagle Pharm Events
Kellaaeg (UTC) (UTC) | Riik | Sündmus |
---|---|---|
No events scheduled |
- Aastas
- Kvartalis
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Kogutulu | 316.61 | 171.546 | 187.802 | 195.892 | 213.312 |
Tulu | 316.61 | 171.546 | 187.802 | 195.892 | 213.312 |
Kulud, Kokku | 94.936 | 42.18 | 45.465 | 60.897 | 61.916 |
Brutokasum | 221.674 | 129.366 | 142.337 | 134.995 | 151.396 |
Kogu tegevuskulu | 235.65 | 168.777 | 154.848 | 174.077 | 176.696 |
Müük/Üldine/admin kulud, kokku | 106.626 | 75.322 | 78.598 | 76.37 | 60.509 |
Uuringud ja arendus | 34.088 | 51.275 | 30.785 | 36.81 | 44.419 |
Ootamatud kulutused (tulu) | 0 | 0 | 10.615 | ||
Tulud majandustegevusest | 80.96 | 2.769 | 32.954 | 21.815 | 36.616 |
Intressitulud (kulu), muud tulud, neto | -3.774 | -7.275 | -2.015 | -0.517 | -2.578 |
Muud, neto | -15.753 | -0.042 | -8.262 | 0.7 | |
Netotulu enne makse | 61.433 | -4.548 | 22.677 | 21.998 | 34.038 |
Netotulu pärast makse | 35.642 | -8.627 | 11.989 | 14.313 | 31.903 |
Netotulu enne erikulusid | 35.642 | -8.627 | 11.989 | 14.313 | 31.903 |
Netotulu | 35.642 | -8.627 | 11.989 | 14.313 | 31.903 |
Total Adjustments to Net Income | |||||
Arvestatav tulu, v a erikulud | 35.642 | -8.627 | 11.989 | 14.313 | 31.903 |
Arvestatav tulu, koos erikuludega | 35.642 | -8.627 | 11.989 | 14.313 | 31.903 |
Jaotamisele kuuluv netotulu | 35.642 | -8.627 | 11.989 | 14.313 | 31.903 |
Keskmine jaotamisele kuuluv aktsia kohta | 13.0655 | 13.0511 | 13.7714 | 14.1387 | 15.2787 |
Jaotatav EPS, v a erakorralised kulud | 2.72795 | -0.66102 | 0.87057 | 1.01233 | 2.08808 |
Jaotamisele kuuluv normaal-EPS | 3.11654 | -0.66102 | 0.87057 | 1.01233 | 2.73926 |
Other Operating Expenses, Total | 0 | 0 | -0.763 | ||
Erakorralised kulud kokku |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
Kogutulu | 60.699 | 65.901 | 74.136 | 115.874 | 42.32 |
Tulu | 60.699 | 65.901 | 74.136 | 115.874 | 42.32 |
Kulud, Kokku | 19.866 | 23.651 | 23.664 | 27.755 | 12.309 |
Brutokasum | 40.833 | 42.25 | 50.472 | 88.119 | 30.011 |
Kogu tegevuskulu | 51.233 | 56.439 | 71.933 | 56.045 | 36.421 |
Müük/Üldine/admin kulud, kokku | 24.15 | 23.462 | 36.832 | 22.182 | 20.325 |
Uuringud ja arendus | 7.217 | 9.326 | 11.437 | 6.108 | 3.787 |
Tulud majandustegevusest | 9.466 | 9.462 | 2.203 | 59.829 | 5.899 |
Intressitulud (kulu), muud tulud, neto | -1.663 | -1.591 | -1.008 | -2.712 | -4.53 |
Muud, neto | 5.501 | -11.534 | -7.063 | 0.543 | -0.145 |
Netotulu enne makse | 13.304 | -3.663 | -5.868 | 57.66 | 1.224 |
Netotulu pärast makse | 8.165 | -7.131 | -9.45 | 44.058 | -6.196 |
Netotulu enne erikulusid | 8.165 | -7.131 | -9.45 | 44.058 | -6.196 |
Netotulu | 8.165 | -7.131 | -9.45 | 44.058 | -6.196 |
Arvestatav tulu, v a erikulud | 8.165 | -7.131 | -9.45 | 44.058 | -6.196 |
Arvestatav tulu, koos erikuludega | 8.165 | -7.131 | -9.45 | 44.058 | -6.196 |
Jaotamisele kuuluv netotulu | 8.165 | -7.131 | -9.45 | 44.058 | -6.196 |
Keskmine jaotamisele kuuluv aktsia kohta | 13.1694 | 13.1669 | 12.8361 | 12.9068 | 12.8948 |
Jaotatav EPS, v a erakorralised kulud | 0.62 | -0.54158 | -0.7362 | 3.41355 | -0.4805 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | ||
Jaotamisele kuuluv normaal-EPS | 0.6234 | -0.54158 | -0.7362 | 3.41355 | -0.4805 |
- Aastas
- Kvartalis
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Käibevarad kokku | 172.606 | 166.065 | 179.449 | 163.844 | 188.697 |
Raha ja lühiajalised investeeringud | 97.659 | 103.155 | 109.775 | 78.791 | 114.657 |
Raha ja ekvivalendid | 97.659 | 103.155 | 109.775 | 78.791 | 114.657 |
Laekumata arved, neto | 41.149 | 51.117 | 48.004 | 66.486 | 53.821 |
Accounts Receivable - Trade, Net | 41.149 | 51.117 | 48.004 | 66.486 | 53.821 |
Total Inventory | 21.908 | 8.075 | 6.566 | 8.304 | 5.118 |
Prepaid Expenses | 11.89 | 3.718 | 15.104 | 10.263 | 15.101 |
Total Assets | 253.732 | 253.19 | 254.554 | 238.603 | 270.06 |
Property/Plant/Equipment, Total - Net | 1.636 | 2.077 | 5.918 | 2.397 | 6.82 |
Property/Plant/Equipment, Total - Gross | 7.591 | 7.268 | 10.237 | 5.744 | 9.258 |
Accumulated Depreciation, Total | -5.955 | -5.191 | -4.319 | -3.347 | -2.438 |
Goodwill, Net | 39.743 | 39.743 | 39.743 | 39.743 | 39.743 |
Intangibles, Net | 10.671 | 12.917 | 15.583 | 18.103 | 23.322 |
Other Long Term Assets, Total | 29.076 | 32.388 | 13.861 | 14.516 | 11.478 |
Total Current Liabilities | 74.376 | 38.085 | 38.823 | 39.686 | 47.302 |
Accounts Payable | 16.431 | 6.268 | 5.462 | 9.917 | 27.036 |
Accrued Expenses | 32.338 | 23.817 | 28.361 | 23.519 | 15.391 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | |||||
Total Liabilities | 77.279 | 67.179 | 75.38 | 77.841 | 90.916 |
Total Long Term Debt | 0 | 25.135 | 33.557 | 38.155 | 42.905 |
Other Liabilities, Total | 2.903 | 3.959 | 3 | 0 | 0.709 |
Total Equity | 176.453 | 186.011 | 179.174 | 160.762 | 179.144 |
Common Stock | 0.017 | 0.017 | 0.017 | 0.017 | 0.016 |
Additional Paid-In Capital | 325.779 | 305.403 | 278.518 | 256.458 | 233.639 |
Retained Earnings (Accumulated Deficit) | 75.862 | 84.489 | 72.5 | 58.187 | 26.284 |
Treasury Stock - Common | -225.111 | -203.898 | -171.861 | -153.9 | -80.795 |
Total Liabilities & Shareholders’ Equity | 253.732 | 253.19 | 254.554 | 238.603 | 270.06 |
Total Common Shares Outstanding | 12.7914 | 13.057 | 13.6302 | 13.914 | 14.8477 |
Current Port. of LT Debt/Capital Leases | 25.607 | 8 | 5 | 6.25 | 4.875 |
Long Term Debt | 0 | 25.135 | 33.557 | 38.155 | 42.905 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | |
Other Equity, Total | -0.094 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Käibevarad kokku | 240.166 | 172.606 | 171.694 | 175.504 | 163.986 |
Raha ja lühiajalised investeeringud | 69.522 | 97.659 | 99.741 | 108.717 | 105.229 |
Raha ja ekvivalendid | 69.522 | 97.659 | 99.741 | 108.717 | 105.229 |
Laekumata arved, neto | 130.858 | 41.149 | 47.081 | 52.659 | 44.868 |
Accounts Receivable - Trade, Net | 130.858 | 41.149 | 45.335 | 52.659 | 44.868 |
Total Inventory | 24.818 | 21.908 | 9.315 | 8.294 | 6.862 |
Prepaid Expenses | 14.968 | 11.89 | 15.557 | 5.834 | 7.027 |
Total Assets | 320.165 | 253.732 | 256.261 | 264.242 | 259.968 |
Property/Plant/Equipment, Total - Net | 1.627 | 1.636 | 1.775 | 1.967 | 2.27 |
Property/Plant/Equipment, Total - Gross | 7.759 | 7.591 | 7.542 | 7.537 | 7.652 |
Accumulated Depreciation, Total | -6.132 | -5.955 | -5.767 | -5.57 | -5.382 |
Goodwill, Net | 39.743 | 39.743 | 39.743 | 39.743 | 39.743 |
Intangibles, Net | 9.94 | 10.671 | 10.799 | 11.505 | 12.211 |
Other Long Term Assets, Total | 28.689 | 29.076 | 32.25 | 35.523 | 41.758 |
Total Current Liabilities | 101.642 | 74.376 | 48.431 | 44.664 | 41.973 |
Accounts Payable | 14.509 | 16.431 | 12.717 | 11.136 | 12.559 |
Accrued Expenses | 63.408 | 32.338 | 27.714 | 25.528 | 21.414 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 23.725 | 25.607 | 8 | 8 | 8 |
Total Liabilities | 104.205 | 77.279 | 70.968 | 69.395 | 68.89 |
Total Long Term Debt | 0 | 0 | 19.489 | 21.371 | 23.253 |
Long Term Debt | 0 | 19.489 | 21.371 | 23.253 | |
Other Liabilities, Total | 2.563 | 2.903 | 3.048 | 3.36 | 3.664 |
Total Equity | 215.96 | 176.453 | 185.293 | 194.847 | 191.078 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock | 0.017 | 0.017 | 0.017 | 0.017 | 0.017 |
Additional Paid-In Capital | 328.769 | 325.779 | 320.566 | 316.249 | 312.323 |
Retained Earnings (Accumulated Deficit) | 119.92 | 75.862 | 82.058 | 87.68 | 84.068 |
Treasury Stock - Common | -233.164 | -225.111 | -216.466 | -208.195 | -205.33 |
Total Liabilities & Shareholders’ Equity | 320.165 | 253.732 | 256.261 | 264.242 | 259.968 |
Total Common Shares Outstanding | 12.6971 | 12.7914 | 12.9446 | 13.0971 | 13.1455 |
Other Equity, Total | 0.418 | -0.094 | -0.882 | -0.904 |
- Aastas
- Kvartalis
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Netotulu/algväärtus | -8.627 | 11.989 | 14.313 | 31.903 | 51.943 |
Raha majandustegevusest | 28.219 | 49.497 | 55.986 | 52.384 | 58.919 |
Raha majandustegevusest | 0.764 | 0.872 | 2.131 | 1.155 | 0.932 |
Amortization | 2.996 | 2.666 | 2.52 | 2.515 | 2.815 |
Deferred Taxes | -3.618 | -1.511 | 0.152 | -2.468 | 17.289 |
Mittelikviidsed varad | 27.167 | 34.665 | 22.478 | 27.168 | 15.509 |
Cash Taxes Paid | 10.005 | 6.428 | 6.673 | 2.281 | 10.542 |
Makstud intressid | 1.197 | 2.224 | 2.478 | 2.084 | 0.651 |
Muutused tööjõus | 9.537 | 0.816 | 14.392 | -7.889 | -29.569 |
Tulu investeeringutelt | -5.323 | -18.247 | -0.777 | -0.133 | -5.186 |
Kapitalikulutused | -0.323 | -0.747 | -0.777 | -0.133 | -5.186 |
Muud rahavood investeeringutelt, kokku | -5 | -17.5 | 0 | 0 | |
Rahavood investeeringutelt | -28.392 | -37.87 | -24.225 | -88.117 | 8.104 |
Rahavoogudesse investeerimine | -1.577 | -1.525 | -0.524 | -19.877 | -1.192 |
Aktsiate emiteerimine (tagasiost), neto | -18.815 | -31.345 | -17.701 | -64.49 | -39.454 |
Rahaline kogumuutus | -5.496 | -6.62 | 30.984 | -35.866 | 61.837 |
Laenu väljastamine (kustutamine), neto | -8 | -5 | -6 | -3.75 | 48.75 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | 44.058 | -8.627 | -2.431 | 3.191 | -0.421 |
Cash From Operating Activities | -16.611 | 28.219 | 20.138 | 19.071 | 10.478 |
Cash From Operating Activities | 0.177 | 0.764 | 0.575 | 0.378 | 0.19 |
Amortization | 0.731 | 2.996 | 2.118 | 1.412 | 0.706 |
Deferred Taxes | -2.432 | -3.618 | -2.533 | 1.119 | 0.902 |
Non-Cash Items | 6.616 | 27.167 | 17.689 | 10.989 | 1.378 |
Cash Taxes Paid | 0.041 | 10.005 | 6.303 | 4.3 | 0.267 |
Cash Interest Paid | 0.265 | 1.197 | 0.917 | 0.625 | 0.321 |
Changes in Working Capital | -65.761 | 9.537 | 4.72 | 1.982 | 7.723 |
Cash From Investing Activities | -0.168 | -5.323 | -5.274 | -5.269 | -5.384 |
Capital Expenditures | -0.168 | -0.323 | -0.274 | -0.269 | -0.384 |
Other Investing Cash Flow Items, Total | 0 | -5 | -5 | -5 | -5 |
Cash From Financing Activities | -11.358 | -28.392 | -18.278 | -8.24 | -3.02 |
Financing Cash Flow Items | -1.305 | -1.577 | -1.551 | -1.551 | -1.551 |
Issuance (Retirement) of Stock, Net | -8.053 | -18.815 | -10.727 | -2.689 | 0.531 |
Issuance (Retirement) of Debt, Net | -2 | -8 | -6 | -4 | -2 |
Net Change in Cash | -28.137 | -5.496 | -3.414 | 5.562 | 2.074 |
Investori nimi | Investori liik | Ringluse protsent | Hoitud osakud | Muutus osakutes | Hoidmise kuupäev | Hinnang käibele |
---|---|---|---|---|---|---|
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 12.5019 | 1635783 | 7863 | 2022-12-31 | LOW |
Tarriff (Scott L) | Individual Investor | 12.2764 | 1606275 | 70900 | 2023-03-01 | LOW |
Janus Henderson Investors | Investment Advisor/Hedge Fund | 9.3996 | 1229872 | -9907 | 2022-12-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 7.2761 | 952026 | -59721 | 2022-12-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 5.8236 | 761974 | -11708 | 2022-12-31 | LOW |
Brandes Investment Partners, L.P. | Investment Advisor | 3.1807 | 416177 | -51680 | 2022-12-31 | LOW |
Adage Capital Management, L.P. | Hedge Fund | 3.0571 | 400000 | 150000 | 2022-12-31 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 2.672 | 349606 | -6153 | 2022-12-31 | LOW |
Renaissance Technologies LLC | Hedge Fund | 2.0379 | 266650 | -7629 | 2022-12-31 | HIGH |
Acadian Asset Management LLC | Investment Advisor/Hedge Fund | 1.77 | 231587 | -79633 | 2022-12-31 | MED |
Smith, Graham & Co. Investment Advisors, L.P. | Investment Advisor | 1.7672 | 231222 | -799 | 2022-12-31 | LOW |
Quoniam Asset Management GmbH | Investment Advisor/Hedge Fund | 1.7569 | 229871 | -55740 | 2022-12-31 | MED |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.5309 | 200305 | 3708 | 2022-12-31 | LOW |
Charles Schwab Investment Management, Inc. | Investment Advisor | 1.2452 | 162931 | 19807 | 2022-12-31 | LOW |
Columbia Threadneedle Investments (US) | Investment Advisor/Hedge Fund | 1.2246 | 160236 | -2596 | 2022-12-31 | LOW |
LSV Asset Management | Investment Advisor | 1.1573 | 151418 | 126068 | 2022-12-31 | LOW |
Allspring Global Investments, LLC | Investment Advisor/Hedge Fund | 1.1512 | 150628 | 62456 | 2022-12-31 | LOW |
Scout Investments, Inc. | Investment Advisor | 1.0749 | 140642 | -2342 | 2022-12-31 | MED |
AQR Capital Management, LLC | Investment Advisor/Hedge Fund | 1.0342 | 135315 | 39400 | 2022-12-31 | LOW |
Morgan Stanley & Co. LLC | Research Firm | 1.0278 | 134477 | -15478 | 2022-12-31 | MED |
Miks valida Capital.com? Meie numbrid räägivad iseenda eest.
Capital.com Group500K+
Kauplejad
92K+
Igakuiste aktiivsete klientide arv
$53M+
Igakuine investeerimise maht
$30M+
Igakuiselt välja võetud
Kauplemiskalkulaator
Arvutage oma hüpoteetiline võit/kaotus, kui oleksite avanud CFD-tehingu ühel kindlal kuupäeval (valige kuupäev) ja sulgenud teisel kuupäeval (valige kuupäev).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Eagle Pharm Company profile
Ettevõttest Eagle Pharm
Eagle Pharmaceuticals, Inc. on integreeritud farmaatsiaettevõte. Ettevõte viib molekuli prekliinilistest uuringutest läbi regulatiivse heakskiitmise ja turuleviimise, sealhulgas arenduse, tootmise ja turustamise. Ettevõte tuvastab kesknärvisüsteemi või metaboolse kriitilise hoolduse ravivaldkondades, samuti onkoloogias esinevaid raskesti ravitavaid haigusi. Ettevõte pakub kolme toodet: Ryanodex, dantroleennaatrium) (Ryanodex), bendamustiini lahjendusvalmis (RTD) 500 ml lahus (Belrapzo) ja kiiresti infundeeritav bendamustiini RTD (Bendeka). Ettevõte turustab Ryanodexi ja Belrapzo ning Teva Pharmaceutical Industries Ltd. (Teva) turustab Bendeka lüofiliseeritud bendamustiinvesinikkloriidi pulbrilist ravimvormi Jaapanis.
Industry: | Proprietary & Advanced Pharmaceuticals |
50 Tice Boulevard, Suite 315
07677
Tuluaruanne
- Annual
- Quarterly
Teised on vaadanud veel
Kas otsite jätkuvalt vahendajat, keda saab usaldada?
Ühinege 500,000+ kauplejaga üle kogu maailma, kes valisid kauplemiseks veebisaidi Capital.com